Excellos has filed a notice of an exempt offering of securities to raise $7 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Excellos is raising $7,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Wellis played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Excellos
Excellos is a unique full-service CDMO that pairs the collection of critical human cells and tissues with manufacturing and development services to drive innovation in the cell and gene therapy industry. Built on the foundation of the San Diego Blood Bank, with over 70 years of experience in blood and tissue collection and handling, Excellos is focused on supplying cGMP cellular products and services, together with process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. Our relationship with the San Diego Blood Bank provides exclusive access to one of the largest and most diverse donor pools available, deep institutional expertise, and connection to a public cord blood bank. Excellos pairs this extraordinary resource with dedicated research and development capabilities to isolate, characterize, store, and transport human cell and tissue samples with the highest quality and viability, setting a new standard across the industry. Based in San Diego, Excellos serves the entire cell and gene therapy industry on a global scale, focusing on therapies in preclinical through phase II/III, and always with a clear scale-up pathway to support commercial level operations. Excellos is dedicated to improving human life by leveraging donor populations for life science research and the next generation of cell and gene therapies. Our goal is to facilitate the advancement of cellular therapies and help fully realize the potential of these powerful therapeutics, saving lives today and improving life tomorrow.
To learn more about Excellos, visit http://www.excellos.com/
Contact:
David Wellis, Chief Executive Officer
858-472-8732
https://www.linkedin.com/in/david-wellis-1a815a1/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.